+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bubble Tea Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 400 Pages
  • August 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5997251
The global bubble tea market has witnessed significant growth, driven by the increasing popularity of this unique beverage across various regions. The market is expected to continue its upward trajectory, with key regions such as South Asia and the Pacific playing a pivotal role in the market's expansion. In 2024, the market is projected to reach a value of approximately USD 1.70 billion, and it is expected to continue expanding at a CAGR of 8.60%, reaching around USD 3.03 billion by 2031. Bubble tea, often recognized for its unique taste and texture, has carved out a significant niche in the global ready-to-drink tea market, reflecting its growing consumer base.

Bubble Tea Consumption Trends and Market Projections

In recent years, the bubble tea market has experienced steady growth, fueled by the rising demand for healthier beverage alternatives. Pearl milk tea, in particular, has gained traction as a popular choice among consumers seeking a refreshing yet nutritious drink. The market is projected to maintain a robust growth rate over the forecast period, with innovations and new product offerings continuing to attract a diverse customer base.

The appeal of bubble tea lies in its versatility and customization options. Consumers can select from a variety of tea bases, which are then enhanced with flavors such as mango, lychee, and other fruits. The addition of traditional tapioca pearls or other toppings like popping boba, lychee jellies, or aloe vera pieces adds to the beverage's appeal, offering a unique texture that sets it apart from other drinks. This trend of customization is expected to drive further growth in the bubble tea market, as consumers increasingly seek personalized beverage experiences.

Factors Bolstering the Demand for Bubble Tea

Consumer preferences in the beverage industry are evolving rapidly, with a growing focus on health and wellness. As a result, bubble tea manufacturers are increasingly using fresh and distinctive ingredients such as fresh fruits, organic cream, and alternative milk options like soy milk. These ingredients not only enhance the flavor and texture of bubble tea but also contribute to its nutritional value, making it a more attractive option for health-conscious consumers.

Milk tea, a key component of bubble tea, offers several health benefits. The inclusion of milk adds not only a rich flavor but also essential nutrients such as calcium, which supports bone health. Additionally, the antioxidants present in tea contribute to overall well-being, while the carbohydrate content provides a quick energy boost. For many working professionals, bubble tea serves as a convenient and enjoyable way to recharge during a busy day.

The presence of caffeine in bubble tea also plays a role in its popularity. Caffeine helps to refresh the body, improving memory and cognitive function. Moreover, the antioxidants in bubble tea can help boost the immune system, protecting against oxidative stress. The addition of fresh fruits like passionfruit and strawberry further enhances the beverage's health benefits, making it an appealing choice for those looking to maintain a healthy lifestyle.

In response to growing concerns about sugar consumption, many consumers are opting for bubble tea made with natural sweeteners such as stevia, agave, or honey. These alternatives offer a way to enjoy the sweet taste of bubble tea without the associated health risks, making it a suitable option for individuals with diabetes or those looking to reduce their sugar intake.

The Influence of Cafés and Quick Service Restaurants on Bubble Tea Demand

The rising popularity of cafés and quick service restaurants, particularly in Asia, has significantly contributed to the growth of the bubble tea market. The expansion of major chains like Starbucks, along with the emergence of specialized bubble tea brands such as Chatime, Koi, and Tiger Sugar, has further fueled this trend. The café culture, especially in South Asia and the Pacific, has embraced bubble tea as a trendy and convenient beverage option.

Consumers in these regions are increasingly drawn to bubble tea due to its unique flavors and the ability to customize their drinks. This trend is expected to continue, with more consumers opting for bubble tea as a preferred beverage in both traditional café settings and quick service restaurants. The expansion of multinational bubble tea brands into new and emerging markets is likely to further drive growth, as these companies capitalize on the untapped potential in these regions.

The low cost of production is another factor contributing to the widespread availability of bubble tea. Ingredients such as tapioca pearls, bubble tea powder, and tea leaves can be purchased in bulk, allowing businesses to produce large quantities of bubble tea at a relatively low cost. This affordability, combined with the beverage's versatility and appeal, makes bubble tea a highly accessible option for consumers around the world.

Market Innovation and Flavor Development

To capture the interest of younger consumers, particularly millennials, bubble tea manufacturers are continually innovating and introducing new flavors. Millennials are known for their enthusiasm for trying new and exciting flavors, making them a key demographic for bubble tea brands. By offering a diverse range of flavors, such as apple, dry fruits, and various milk-based options, companies can appeal to this adventurous consumer base.

Reducing sugar content or substituting traditional sweeteners with healthier options like brown sugar is another area of focus for bubble tea manufacturers. This shift not only caters to health-conscious consumers but also aligns with broader trends in the food and beverage industry, where there is increasing demand for products with reduced sugar and healthier ingredients.

The introduction of new flavored bubble tea products is expected to drive sales and create opportunities for manufacturers to expand into new markets. As companies continue to innovate and adapt to changing consumer preferences, the bubble tea market is likely to see sustained growth. However, challenges such as high costs in certain regions and low market penetration in others may require strategic efforts to ensure continued expansion.

Challenges Facing the Bubble Tea Market

Despite its popularity, the bubble tea market faces certain challenges that could impact its growth. One of the primary concerns is the high sugar content found in many bubble tea beverages. As consumers become more aware of the negative health effects associated with excessive sugar consumption, there may be a shift away from sugary drinks, including bubble tea.

Bubble tea is known for its high calorie content, which can be a deterrent for health-conscious consumers. Regular consumption of bubble tea, particularly those with high sugar levels, can lead to health issues such as diabetes, tooth decay, and weakened immunity. Additionally, bubble tea is often high in carbohydrates while lacking essential nutrients like vitamins, minerals, and fiber.

Health experts have warned about the potential risks associated with the regular consumption of high-calorie beverages like bubble tea. This has led to a growing preference for organic and natural beverages, which do not contain artificial preservatives or high levels of sugar. As a result, the bubble tea market may face challenges in retaining its consumer base, particularly among those who prioritize health and wellness.

Regional Insights: Europe and Latin America

In Europe, the bubble tea market has seen significant growth, with certain countries emerging as major markets. The United Kingdom, for example, has shown a strong appetite for bubble tea, with consumers eager to try new and innovative beverages. This trend is expected to continue, with the U.K. market likely to expand further in the coming years.

Similarly, in Latin America, the bubble tea market is gaining traction, particularly in Brazil. Increased awareness of bubble tea as a unique and flavorful beverage has contributed to its rising popularity in the region. As demand continues to grow, the market in Latin America is poised for further expansion.

Popular Bubble Tea Toppings and Distribution Channels

Tapioca pearls remain the most popular topping for bubble tea, though other options like popping boba and jellies are also gaining popularity. The demand for these innovative toppings is expected to boost overall sales, as consumers seek out new and exciting ways to enjoy their bubble tea.

In terms of distribution channels, business-to-consumer sales of bubble tea are showing promising growth. The convenience of ready-to-drink cans and instant mix kits has made bubble tea more accessible to a wider audience, contributing to its growing popularity.

Competitive Landscape and Future Outlook

Leading bubble tea brands are focusing on expanding their presence in new markets to gain a competitive edge. Companies like Gong Cha, Sharetea, and Tiger Sugar are establishing their brands across multiple regions, leveraging franchise models to accelerate growth. This expansion is expected to drive further market penetration and increase brand visibility.

As the bubble tea market continues to evolve, companies will need to balance innovation with consumer demands for healthier options. The ongoing development of new flavors and healthier ingredients will be key to sustaining growth and ensuring the long-term success of the bubble tea market.

Key companies profiled

  • Bobble Bobble
  • Yen Chuan International Co., Ltd
  • Gong Cha USA
  • Empire Eagle Food Co., Ltd.
  • Quickly Corporation
  • Boba Guys, Inc.
  • Chatime
  • 8tea5
  • Kung Fu Tea
  • Ten Ren Tea, Inc.
  • Tapioca Express, Inc.
  • Boise Boba
  • Woop Bubble Tea
  • Coco Tea
  • Sharetea
  • BobaTea Factory
  • Possmei international Co., Ltd
  • Bubble Tea House Company
  • The Inspire Food Company
  • TACHUNGHO

Bubble Tea Industry Survey by Category

Bubble Tea Market by Base Ingredient:

  • Black Tea
  • Green Tea
  • Oolong Tea
  • White Tea

Bubble Tea Market by Flavor:

  • Unflavored Bubble Tea
  • Flavored Bubble Tea
  • Taro
  • Coffee
  • Fruit Flavors
  • Others

Bubble Tea Market by Format:

  • Ready-to-Drink Bubble Tea
  • Instant Bubble Tea Mix Kits

Bubble Tea Market Topping:

  • Tapioca Pearls
  • Popping Boba
  • Jellies
  • Others

Bubble Tea Market by Distribution Channel:

  • Business to Business Sales of Bubble Tea
  • Business to Consumer Sales of Bubble Tea
  • Hypermarkets/Supermarkets
  • Convenience Stores
  • Online Retail

Bubble Tea Market by Region:

  • North America Bubble Tea Market
  • Latin America Bubble Tea Market
  • Europe Bubble Tea Market
  • South Asia and Pacific Bubble Tea Market
  • East Asia Bubble Tea Market
  • The Middle East and Africa Bubble Tea Market


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Bubble Tea Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Bubble Tea Market Outlook, 2019 - 2031
3.1. Global Bubble Tea Market Outlook, by Therapy Type, Value (US$ Bn), 2019 - 2031
3.1.1. Key Highlights
3.1.1.1. Monotherapy
3.1.1.1.1. Pirfenidone Therapy
3.1.1.1.2. Nintedanib Therapy
3.1.1.1.3. Corticosteroids Therapy
3.1.1.1.4. Combination Therapy
3.1.1.1.5. Pirfenidone & Corticosteroid
3.1.1.1.6. Nintedanib & Corticosteroid
3.1.1.1.7. Pirfenidone & Antitussive
3.1.1.1.8. Others
3.1.1.2. Symptomatic Treatment
3.2. Global Bubble Tea Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
3.2.1. Key Highlights
3.2.1.1. Idiopathic Pulmonary Fibrosis (IPF)
3.2.1.2. Familial PF
3.2.1.3. Others
3.3. Global Bubble Tea Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospital Pharmacy
3.3.1.2. Retail Pharmacy
3.3.1.3. Mail Order Pharmacy
3.4. Global Bubble Tea Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Bubble Tea Market Outlook, 2019 - 2031
4.1. North America Bubble Tea Market Outlook, by Therapy Type, Value (US$ Bn), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1. Monotherapy
4.1.1.1.1. Pirfenidone Therapy
4.1.1.1.2. Nintedanib Therapy
4.1.1.1.3. Corticosteroids Therapy
4.1.1.1.4. Combination Therapy
4.1.1.1.5. Pirfenidone & Corticosteroid
4.1.1.1.6. Nintedanib & Corticosteroid
4.1.1.1.7. Pirfenidone & Antitussive
4.1.1.1.8. Others
4.1.1.2. Symptomatic Treatment
4.2. North America Bubble Tea Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Idiopathic Pulmonary Fibrosis (IPF)
4.2.1.2. Familial PF
4.2.1.3. Others
4.3. North America Bubble Tea Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospital Pharmacy
4.3.1.2. Retail Pharmacy
4.3.1.3. Mail Order Pharmacy
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Bubble Tea Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
4.4.1.2. U.S. Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
4.4.1.3. U.S. Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
4.4.1.4. Canada Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
4.4.1.5. Canada Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
4.4.1.6. Canada Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Bubble Tea Market Outlook, 2019 - 2031
5.1. Europe Bubble Tea Market Outlook, by Therapy Type, Value (US$ Bn), 2019 - 2031
5.1.1. Key Highlights
5.1.1.1. Monotherapy
5.1.1.1.1. Pirfenidone Therapy
5.1.1.1.2. Nintedanib Therapy
5.1.1.1.3. Corticosteroids Therapy
5.1.1.1.4. Combination Therapy
5.1.1.1.5. Pirfenidone & Corticosteroid
5.1.1.1.6. Nintedanib & Corticosteroid
5.1.1.1.7. Pirfenidone & Antitussive
5.1.1.1.8. Others
5.1.1.2. Symptomatic Treatment
5.2. Europe Bubble Tea Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
5.2.1. Key Highlights
5.2.1.1. Idiopathic Pulmonary Fibrosis (IPF)
5.2.1.2. Familial PF
5.2.1.3. Others
5.3. Europe Bubble Tea Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospital Pharmacy
5.3.1.2. Retail Pharmacy
5.3.1.3. Mail Order Pharmacy
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Bubble Tea Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.2. Germany Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.3. Germany Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.4. U.K. Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.5. U.K. Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.6. U.K. Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.7. France Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.8. France Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.9. France Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.10. Italy Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.11. Italy Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.12. Italy Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.13. Turkey Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.14. Turkey Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.15. Turkey Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.16. Russia Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.17. Russia Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.18. Russia Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.1.19. Rest of Europe Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
5.4.1.20. Rest of Europe Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
5.4.1.21. Rest of Europe Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Cassava Starch Market Outlook, 2019 - 2031
6.1. Asia Pacific Cassava Starch Market Outlook, by Therapy Type, Value (US$ Bn), 2019 - 2031
6.1.1. Key Highlights
6.1.1.1. Monotherapy
6.1.1.1.1. Pirfenidone Therapy
6.1.1.1.2. Nintedanib Therapy
6.1.1.1.3. Corticosteroids Therapy
6.1.1.1.4. Combination Therapy
6.1.1.1.5. Pirfenidone & Corticosteroid
6.1.1.1.6. Nintedanib & Corticosteroid
6.1.1.1.7. Pirfenidone & Antitussive
6.1.1.1.8. Others
6.1.1.2. Symptomatic Treatment
6.2. Asia Pacific Bubble Tea Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
6.2.1. Key Highlights
6.2.1.1. Idiopathic Pulmonary Fibrosis (IPF)
6.2.1.2. Familial PF
6.2.1.3. Others
6.3. Asia Pacific Bubble Tea Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospital Pharmacy
6.3.1.2. Retail Pharmacy
6.3.1.3. Mail Order Pharmacy
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Bubble Tea Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
6.4.1. Key Highlights
6.4.1.1. China Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
6.4.1.2. China Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.3. China Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.4. Japan Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
6.4.1.5. Japan Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.6. Japan Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.7. South Korea Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
6.4.1.8. South Korea Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.9. South Korea Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.10. India Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
6.4.1.11. India Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.12. India Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.13. Southeast Asia Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
6.4.1.14. Southeast Asia Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.15. Southeast Asia Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.1.16. Rest of Asia Pacific Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
6.4.1.17. Rest of Asia Pacific Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
6.4.1.18. Rest of Asia Pacific Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Bubble Tea Market Outlook, 2019 - 2031
7.1. Latin America Bubble Tea Market Outlook, by Therapy Type, Value (US$ Bn), 2019 - 2031
7.1.1. Key Highlights
7.1.1.1. Monotherapy
7.1.1.1.1. Pirfenidone Therapy
7.1.1.1.2. Nintedanib Therapy
7.1.1.1.3. Corticosteroids Therapy
7.1.1.1.4. Combination Therapy
7.1.1.1.5. Pirfenidone & Corticosteroid
7.1.1.1.6. Nintedanib & Corticosteroid
7.1.1.1.7. Pirfenidone & Antitussive
7.1.1.1.8. Others
7.1.1.2. Symptomatic Treatment
7.2. Latin America Bubble Tea Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
7.2.1.1. Idiopathic Pulmonary Fibrosis (IPF)
7.2.1.2. Familial PF
7.2.1.3. Others
7.3. Latin America Bubble Tea Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospital Pharmacy
7.3.1.2. Retail Pharmacy
7.3.1.3. Mail Order Pharmacy
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Bubble Tea Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
7.4.1.2. Brazil Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
7.4.1.3. Brazil Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.4.1.4. Mexico Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
7.4.1.5. Mexico Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
7.4.1.6. Mexico Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.4.1.7. Argentina Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
7.4.1.8. Argentina Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
7.4.1.9. Argentina Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.4.1.10. Rest of Latin America Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
7.4.1.11. Rest of Latin America Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
7.4.1.12. Rest of Latin America Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Bubble Tea Market Outlook, 2019 - 2031
8.1. Middle East & Africa Bubble Tea Market Outlook, by Therapy Type, Value (US$ Bn), 2019 - 2031
8.1.1. Key Highlights
8.1.1.1. Monotherapy
8.1.1.1.1. Pirfenidone Therapy
8.1.1.1.2. Nintedanib Therapy
8.1.1.1.3. Corticosteroids Therapy
8.1.1.1.4. Combination Therapy
8.1.1.1.5. Pirfenidone & Corticosteroid
8.1.1.1.6. Nintedanib & Corticosteroid
8.1.1.1.7. Pirfenidone & Antitussive
8.1.1.1.8. Others
8.1.1.2. Symptomatic Treatment
8.2. Middle East & Africa Bubble Tea Market Outlook, by Indication, Value (US$ Bn), 2019 - 2031
8.2.1. Key Highlights
8.2.1.1. Idiopathic Pulmonary Fibrosis (IPF)
8.2.1.2. Familial PF
8.2.1.3. Others
8.3. Middle East & Africa Bubble Tea Market Outlook, by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.3.1.1. Hospital Pharmacy
8.3.1.2. Retail Pharmacy
8.3.1.3. Mail Order Pharmacy
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Bubble Tea Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
8.4.1.2. GCC Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.3. GCC Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.1.4. South Africa Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
8.4.1.5. South Africa Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.6. South Africa Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.1.7. Egypt Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
8.4.1.8. Egypt Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.9. Egypt Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.1.10. Nigeria Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
8.4.1.11. Nigeria Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.12. Nigeria Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.1.13. Rest of Middle East & Africa Bubble Tea Market by Therapy Type, Value (US$ Bn), 2019 - 2031
8.4.1.14. Rest of Middle East & Africa Bubble Tea Market by Indication, Value (US$ Bn), 2019 - 2031
8.4.1.15. Rest of Middle East & Africa Bubble Tea Market by Distribution Channel, Value (US$ Bn), 2019 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Distribution Channel vs by Indication Heat map
9.2. Manufacturer vs by Indication Heatmap
9.3. Company Market Share Analysis, 2024
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. F. Hoffman - La Roche Ltd.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Boehringer Ingelheim
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. International GmbH
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Cipla Ltd (Cipla)
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Gilead Sciences, Inc.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Bristol-Myers Squibb Company
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. FibroGen Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Galecto, Inc.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Gong Cha
  • Kung Fu Tea
  • Tiger Sugar
  • Sharetea
  • Boba Guys
  • Tapioca Express
  • Chatime
  • Tea Ren’s Tea Time
  • CoCo Fresh Tea & Juice
  • Quickly
  • Happy Lemon
  • DaBoba
  • Cojiitii
  • TACHUNGHO

Methodology

Loading
LOADING...